Showing 31-40 of 42 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Tirzepatide with fully automated insulin delivery | The Research Institute of the McGill University Health Centre | Ahmad Haidar | Improving Lives | 01-September-2025 to 31-August-2028 | $1,885,343.91 |
| Type 1 Diabetes TrialNet Canadian Network | The Hospital for Sick Children | Diane Wherrett | Cures | 01-June-2026 to 31-May-2031 | $199,995.00 |
| mRNA/LNP-based Epigenetic Immunomodulation to Restore Tolerance in T1D | The Governing Council of the University of Toronto | BOWEN LI | Cures | 01-April-2026 to 31-March-2027 | $199,998.79 |
| Picosecond Infrared Laser (PIRL)-based spatial imaging mass spectrometry (proteomics) and transcriptomics of beta-cells in live human pancreas slices afflicted by T1D T-cell immune injury | The Governing Council of the University of Toronto | Herbert Gaisano | Cures | 01-April-2026 to 31-March-2027 | $199,430.00 |
| Synthetic vascularizing biomaterial platform for subcutaneous islet transplantation and immunomodulation | The Governing Council of the University of Toronto | Sean Kinney | Cures | 01-March-2025 to 29-February-2028 | $237,690.00 |
| Development of targeted nanoparticles for delivering therapeutics to islet cells for treatment of T1D | The Governing Council of the University of Toronto | Xiao Yu (Shirley) Wu | Cures | 01-April-2023 to 31-March-2027 | $899,710.00 |
| Regenerating Human Pancreatic β Cells to Treat Diabetes | Sunnybrook Research Institute | Robert Screaton | Cures | 01-May-2022 to 31-May-2027 | $900,000.00 |
| Safe and Immune Cloaked Stem Cell-Derived Beta-Cells: Treatment for Type 1 Diabetes Mellitus | Sinai Health System | Andras Nagy | Cures | 01-October-2022 to 30-September-2027 | $1,474,390.51 |
| Development of an antigen-specific lipid nanoparticle mRNA therapy for T1D | Integrated Nanotherapeutics, Inc | Chris Tam | Cures | 01-June-2024 to 30-November-2026 | $750,000.00 |
| A combined chemical synthetic / intravital imaging approach to explore the survival and function of human pluripotent derived islets after transplantation in mice. | Centre hospitalier de l’Universite de Montreal (CHUM) | Guy Rutter | Cures | 01-April-2025 to 31-March-2027 | $599,959.77 |